# Protocol for the Specified Clinical Experience Investigation on the Single Use of Casodex® Tablet 80 mg

> **NCT00919477** · — · COMPLETED · sponsor: **AstraZeneca** · enrollment: 712 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00919477
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2009-05
- **Primary completion:** 2012-03
- **Final completion:** 2012-03
- **Target enrollment:** 712 (ACTUAL)
- **Last updated:** 2013-01-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00919477

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00919477, "Protocol for the Specified Clinical Experience Investigation on the Single Use of Casodex® Tablet 80 mg". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00919477. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*